American Journal of Immunology - Polymyositis initiation involving amlodipine besylate
January 1, 2006 -- Abstract: Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis...
Business Wire - Teva Announces Approval of Amlodipine Besylate Tablets
June 29, 2007 -- JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has granted...
Business Wire - Teva Announces Tentative Approval of Amlodipine Besylate Tablets
March 27, 2005 -- JERUSALEM, Israel -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that the U.S. Food and Drug Administration has granted...
Business Wire - Pfizer Announces Launch of Generic Amlodipine Besylate Product by Greenstone
March 23, 2007 -- NEW YORK -- In response to an announcement today by Mylan Laboratories that it has launched a generic competitor to Norvasc, Pfizer said it is making...
Business Wire - Dr. Reddy's confirms ANDA filing for Amlodipine Besylate tablets
February 24, 2004 -- Business Editors/Health/Medical Writers HYDERABAD, India--(BUSINESS WIRE)--Feb. 24, 2004 Dr. Reddy's Laboratories (NYSE:RDY) today confirmed that...
M2 Presswire - Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs.
March 27, 2007 -- M2 PRESSWIRE-27 March 2007-Afternoon Movers: Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate...
Market Wire - Daiichi Sankyo, Inc. Announces Filing of New Drug Application for Amlodipine Besylate / Olmesartan Medoxomil Combination for the Treatment of Hypertension
November 28, 2006 -- Daiichi Sankyo, Inc. announced today that ithas filed a New Drug Application (NDA) with the U.S. Food and DrugAdministration (FDA) for a fixed dose...
Business Wire - Federal Court in Canada Upholds Pfizer's Norvasc Patent; Decision Prevents Launch of Generic Amlodipine Besylate Product by Pharmascience until 2010
April 17, 2008 -- NEW YORK -- Pfizer Inc said today that the Canadian Federal Court has upheld a Pfizer patent covering amlodipine besylate, the active ingredient in...
PR Newswire Europe - New Research Shows That Single Pill amlodipine besylate/atorvastatin calcium May Reduce 10-Year Risk for a Heart Attack or Stroke by More Than 50 Percent.
October 18, 2006 -- FUKUOKA, Japan, October 18 /PRNewswire/ -- - Therapy May Benefit Hypertensive Patients With Additional Risk Factors in Populations Across Asia...
